Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MHLW Doubles Budget For Generic Drug Use Promotion Measures

This article was originally published in PharmAsia News

Executive Summary

Japan's Ministry of Health, Labor and Welfare doubled its budget request for promotion measures of generic drug use in fiscal year 2009. The budge requested ¥91 million compared to ¥45 million appropriated in FY2008. The increased amount will be used to establish programs at the local level to raise public awareness and further generic drug use, which is key to the government's goal of keeping social security increases within ¥210 billion annually. In addition, the budget also requested ¥146 million for information gathering in generic drug's quality, ¥45 million for quality assurance and ¥7 million to conduct market research of generic drug use in Europe and the U.S. (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069532

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel